NaturalNano Announces Dr. King's Scientific Paper Published on Capture of Circulating Tumor Cells From Blood Using Halloysite...
March 15 2012 - 10:00AM
NaturalNano, Inc. (OTCBB:NNAN) (www.naturalnano.com) announced
today that Dr. Michael King of Cornell University published his new
technique for the isolation of circulating tumor cells
(CTC) using NaturalNano's halloysite nanotubes. Dr.
King's report explains his lab's recent work showing how thin
coatings of naturally-forming halloysite nanotubes can greatly
improve the efficiency of CTC capture from patient blood samples
under flow.
Dr. King, an associate professor of Biomedical Engineering at
Cornell University, states, "The isolation of circulating tumor
cells (CTCs) from blood samples can be targeted more effectively by
incorporation of halloysite nanotubes (HNT) onto the surface of
flow devices used to capture CTCs in blood." King continued, "We
present a new lab protocol that utilizes off-the-shelf materials
and standard equipment, so clinical and research labs will be able
to utilize the method without difficulty."
James Wemett, NaturalNano CEO, said, "We are pleased to have Dr.
King's work with our HNT materials published. Wemett continued,"Dr.
King's work with HNT continues to build on our understanding of the
potential role that HNT may play in life science applications."
The abstract can be viewed at the following link:
http://www.clinchem.org/content/early/2012/02/16/clinchem.2011.176669.abstract
or contact Dr. King for further details.
About NaturalNano, Inc.
NaturalNano, Inc. (OTCBB:NNAN) is a materials science company
focused on developing and commercializing advanced nanocomposites.
The Company is focused on additive technologies and processes,
including its proprietary Pleximer that adds value to industrial
polymers, plastics and composites. NaturalNano holds and/or
licenses 20 patents and applications relating to Halloysite,
as well as proprietary know-how for its extraction and separation
processes, compositions, and
derivatives. www.naturalnano.com
Cautionary Statement Regarding Forward-Looking
Statements: Contains forward-looking statements regarding
future events and future performance that involve risks and
uncertainties that could materially affect actual results. This
information is qualified in its entirety by cautionary statements
and risk factors disclosure contained in certain of NaturalNano's
filings with the Securities and Exchange Commission. The most
recent annual reports on Form 10-K and quarterly reports on Form
10-Q filed by NaturalNano provide information about these factors,
which may be revised or supplemented in future reports to the SEC
on those forms or on Form 8-K. We caution investors not to place
undue reliance on forward-looking statements, and we do not
undertake any obligation to update or otherwise revise any
forward-looking statements, whether as a result of new information,
future events, or other such factors that affect the subject of
these statements, except where expressly required by law.
CONTACT: Jim Wemett
info@naturalnano.com
NaturalNano, Inc.
585-267-4848